Real Estate, Mortgage News

Real Estate News and Press Release Distribution Services
Submit Press Release | Submit RSS Feed | About US | Contact Us

Home | Real Estate News | Mortgage Rates
Unlimited Press Release Distribution
Press release distribution service


News Media
CNN Money
Costar Group
Inman News


Los Angeles Times


National Real Estate Investor
Mortgage News Daily
New York Times
Realtor Magazine
RISMedia
Wall Street Journal
Yahoo Finance
Zawya
RSS News Feed
Get your news feed listed here as other news media shown below! Submit RSS News Feed

Mercury News
New York Post

Real Estate News Releases

Allegiance Equity Corporation Announces Positive Results of In Vitro Studies and an Open Label Trial for Relieva(R) in Treating Atopic Dermatitis

(EMAILWIRE.COM, February 21, 2007 ) TORONTO -- Prime Pharmaceutical Corporation (with 37.5% equity interest held by Allegiance Equity Corporation (TSXV: ANQ)) is pleased to announce that its licensee, Apollo Pharmaceuticals, has conducted preclinical research studies to characterize the Pharmacological profile of Relieva®, a topical preparation containing Psorberine in Novasome®, a proprietary liposome formulation. The in vitro studies to specifically determine the immunoregulatory effects of Psorberine show that: 1. It inhibits the growth of bacteria. 2. It inhibits the release of the pro-inflammatory cytokines such as IL-8, TNF-alpha and IL-1beta, as well as the inflammatory cytokine IL-2. This effect of Psorberine may contribute to its anti-inflammatory activity. 3. It inhibits the chemotaxis of T cells toward chemokines. An activity that is important for any anti-inflammatory compound.The anti-inflammatory and antibacterial activity of psorberine suggests that it might be useful in patients with Atopic Dermatitis.To determine the efficacy and tolerability of Relieva® in adult patients with Atopic Dermatitis, an open label study was conducted in the USA. Forty two patients were enrolled in the 12 week trial. The study was very successful and the final results will be available as soon as the analysis is completed.Relieva® for PsoriasisPsoriasis is an incurable skin disease that is characterized by rapid cell proliferation and inflammation. It affects 3% of the world's population, and The Medical Technology Stock Letter estimates the global market for psoriasis therapies to exceed $7 billion annually. Current treatments are primarily topical creams and ointments, most of which have side effects or safety concerns that preclude long-term use.A major new clinical trial accepted and published in the American Journal of Therapeutics (American Journal of Therapeutics 13, pp.121-126 (2006)) recognized that Prime's Relieva® is a major breakthrough in the treatment of psoriasis providing effective relief without side effects. For further information visit www.relievaforpsoriasis.comThe TSX Venture Exchange has not reviewed and does not accept responsibility FOR THE ADEQUACY OR ACCURACY FOR THIS PRESS RELEASE, WHICH HAS BEEN PREPARED BY MANAGEMENT.For further information on Allegiance Equity Corporation, contact David Solomon, President, by telephone at 416-944-2840 or dsolomon@primepharmaceutical.com or visit www.allegianceequity.com.



Joseph Nchor

info@groupweb.com


Real Estate News by Sector
  • Appraiser
  • Consumer News
  • Commercial
  • Mortgage News
  • Property Law
  • REIT News
  • Sales, Marketing
  • Technology

  • Real Estate RSS Marketpalce

    Submit RSS news feed on Real Estate.
    Have your feed on real estate news, products or services displayed under this marketpalce and have your feed on a full page updated daily. Click on example below. Add RSS feed Now!

    EmailWire Real Estate News Releases
    News releases on real estate as posted by businesses, organizations and experts.


    Press release service

    ESTATENewswire is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

    For unlimited press release distribution for $99 per month or $999 per year, call (281) 645-4086 or start posting your press releases online at EmailWire.com.
    Copyright 2009 GroupWeb Media LLC

    GroupWeb Media Network
    AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
    | InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
    ESTATENewswire.Com - Newswire and Press Release service of GroupWeb Media LLC